Junshi Biosciences
Shanghai, China· Est.
A commercial Chinese biopharma with a broad pipeline in oncology, immunology, and infectious disease.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
A commercial Chinese biopharma with a broad pipeline in oncology, immunology, and infectious disease.
OncologyImmunologyInfectious Disease
Technology Platform
A comprehensive therapeutic antibody discovery and engineering platform, complemented by small molecule research capabilities.
Opportunities
Potential to leverage its broad pipeline and commercial infrastructure to capture significant market share in China's growing biopharma sector.
Risk Factors
High commercial competition and pricing erosion in key therapeutic areas like oncology could pressure revenue and profitability.
Competitive Landscape
A leading domestic innovator facing fierce competition in core markets like PD-1 inhibitors, both from local peers and global pharmaceutical companies.